One extraordinary characteristic of this pandemic period has been stock market performance. A recent Wall Street Journal headline captures it perfectly: “Turbocharged stocks blast off.” In its third-quarter market’s review, the Journal points out that “more stocks skyrocketed at least 400% in the first three quarters of the year than in any comparable period since 2000.”

This is not a tide that is lifting all boats, anything but. The overwhelming majority of the winners are tech or biotech-related.

Whether value’s short-lived outperformance will continue is of particular interest to this week’s guest. She is Sarah Ketterer, Chief Executive Officer of Causeway Capital Management. The combination of its deep value and international focus has proven to be challenging in this era of high performing tech and U.S. centric stocks, but Ketterer and her colleagues now call this a value investor’s dream market as more high quality, financially strong companies sell at “shockingly” cheap valuations.

Ketterer will discuss which ones, in particular, have caught her eye.